HomeCompareNPKYF vs KMB

NPKYF vs KMB: Dividend Comparison 2026

NPKYF yields 5.37% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPKYF wins by $972.4K in total portfolio value
10 years
NPKYF
NPKYF
● Live price
5.37%
Share price
$8.44
Annual div
$0.45
5Y div CAGR
50.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.02M
Annual income
$635,355.05
Full NPKYF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — NPKYF vs KMB

📍 NPKYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPKYFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPKYF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPKYF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPKYF
Annual income on $10K today (after 15% tax)
$456.12/yr
After 10yr DRIP, annual income (after tax)
$540,051.79/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, NPKYF beats the other by $535,612.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPKYF + KMB for your $10,000?

NPKYF: 50%KMB: 50%
100% KMB50/50100% NPKYF
Portfolio after 10yr
$532.1K
Annual income
$320,288.70/yr
Blended yield
60.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

NPKYF
No analyst data
Altman Z
2.8
Piotroski
3/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPKYF buys
0
KMB buys
0
No recent congressional trades found for NPKYF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPKYFKMB
Forward yield5.37%5.25%
Annual dividend / share$0.45$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.8%17%
Portfolio after 10y$1.02M$45.9K
Annual income after 10y$635,355.05$5,222.34
Total dividends collected$956.6K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NPKYF vs KMB ($10,000, DRIP)

YearNPKYF PortfolioNPKYF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$11,509$809.21$11,314$614.45+$195.00NPKYF
2$13,627$1,312.58$12,867$760.19+$760.00NPKYF
3$16,772$2,190.33$14,713$945.27+$2.1KNPKYF
4$21,745$3,799.19$16,924$1,181.90+$4.8KNPKYF
5$30,209$6,942.06$19,596$1,486.64+$10.6KNPKYF
6$45,916$13,592.11$22,850$1,882.16+$23.1KNPKYF
7$78,246$29,115.83$26,849$2,399.80+$51.4KNPKYF
8$153,650$69,927.02$31,812$3,083.36+$121.8KNPKYF
9$357,929$193,523.76$38,033$3,994.72+$319.9KNPKYF
10$1,018,339$635,355.05$45,918$5,222.34+$972.4KNPKYF

NPKYF vs KMB: Complete Analysis 2026

NPKYFStock

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Full NPKYF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this NPKYF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPKYF vs SCHDNPKYF vs JEPINPKYF vs ONPKYF vs KONPKYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.